A Research Study to See How a New Medicine (NNC0487-0111) Works in People With Overweight or Obesity When Injected Under the Skin

Completed · Phase 2 · Has a placebo group

Conditions studied: Obesity, Overweight

In brief

The purpose of the study is to evaluate if a new study drug, NNC0487-0111, is safe and how it works in the participant's body, when given as injections under the skin

Key facts

Study ID
NCT06064006
Run by
Novo Nordisk A/S
People needed
125
Starts
2023-09-15
Expected to finish
2024-11-27
Last updated by the study team
2025-11-19

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.